Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Total Current Liabilities (2023 - 2025)

Rallybio's Total Current Liabilities history spans 3 years, with the latest figure at $4.5 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 44.82% year-over-year to $4.5 million; the TTM value through Sep 2025 reached $4.5 million, down 44.82%, while the annual FY2024 figure was $6.2 million, 32.61% down from the prior year.
  • Total Current Liabilities for Q3 2025 was $4.5 million at Rallybio, up from $3.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $10.1 million in Q1 2024 and bottomed at $3.9 million in Q1 2025.
  • The 3-year median for Total Current Liabilities is $7.4 million (2023), against an average of $7.1 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 48.32% in 2024 before it tumbled 61.23% in 2025.
  • A 3-year view of Total Current Liabilities shows it stood at $9.3 million in 2023, then tumbled by 32.61% to $6.2 million in 2024, then decreased by 27.6% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Total Current Liabilities are $4.5 million (Q3 2025), $3.9 million (Q1 2025), and $6.2 million (Q4 2024).